SRDX Valuation

Surmodics Inc

Add to Watchlist

Advanced Chart

28.490

+1.250(+4.590%)

Overview
Forecast
Valuation

SRDX Relative Valuation

SRDX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SRDX is overvalued; if below, it's undervalued.

Historical Valuation

Surmodics Inc (SRDX) is now in the Undervalued zone, suggesting that its current forward PS ratio of 3.02 is considered Undervalued compared with the five-year average of 4.74. The fair price of Surmodics Inc (SRDX) is between 30.63 to 52.02 according to relative valuation methord. Compared to the current price of 28.49 USD , Surmodics Inc is Undervalued By 6.99%.

Relative Value

Fair Zone

30.63-52.02

Current Price：28.49

6.99%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

3.64

P/B

Median3y

4.02

Median5y

4.33

-0.50

FCF Yield

Median3y

-1.55

Median5y

-0.18

Competitors Valuation Multiple

The average P/S ratio for SRDX's competitors is 2.58, providing a benchmark for relative valuation. Surmodics Inc Corp (SRDX) exhibits a P/S ratio of 3.02, which is 17.37% above the industry average. Given its robust revenue growth of -2.06%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap